In all probability, children could get Covid-19 vaccine jab by September this year. Speaking to news agency ANI, AIIMS Chief Dr Randeep Guleria informed that the trials of Bharat Biotech’s Covaxin on children are underway and the results are expected by September.
While the second dose of Covaxin has already been administered to children of 6-12 years in trials at the Delhi AIIMS, Covaxin second dose is likely to be administered to children aged 2-6 years in trials next week. According to the AIIMS Chief, vaccines for children should be available in the coming weeks or by September.
Following the vaccination drive of children, schools can be reopened in a graded manner, Dr Gularia said. Guleria said that this vaccination drive ahead of reopening of schools will provide protection to children and give confidence to the public that children are safe.
As per reports, the vaccine trials are being conducted in three phases by segregating children into various categories based on their age. Meanwhile, Zydus Cadilla has applied to the DCGI for emergency use authorisation of vaccine ZyCov-D, claiming that they have included data for children for the vaccine, the AIIMS chief said.
Flashback 2022 - Biggest Moments Of The Year The World Witnessed
According to NFHS, Alcohol consumption in men & women is higher in rural India than urban India. According to the survey, 1% of women aged 15 and above drink alcohol, compared to 19% of men in the same age group.
Odisha reported 51,968 forest fires between November 2020 and June 2021, which was the highest in the country during the period.
Tesla CEO and the current Twitter boss Elon Musk said that he would reverse the Twitter ban on former US president Donald Trump.
Flashback 2022 - Biggest Moments Of The Year The World Witnessed
According to NFHS, Alcohol consumption in men & women is higher in rural India than urban India. According to the survey, 1% of women aged 15 and above drink alcohol, compared to 19% of men in the same age group.
Copyright © 2024 - Odisha Television Limited All Rights Reserved.